NTRK Gene Fusion Test Cost | Lahalak Medical Platform

A sophisticated genetic test identifying rare NTRK fusions that drive tumor growth. This allows oncologists to select precise targeted therapies that treat the genetic cause regardless of the primary cancer location.

Scientific name: NTRK Gene Fusion Comprehensive Testing

A comprehensive molecular analysis detecting NTRK gene fusions in tumor cells. This test serves as a critical biomarker to identify patients eligible for modern TRK inhibitor therapies, offering personalized treatment options.

NTRK Gene Fusion Comprehensive Testing - Precision Targeted Cancer Therapy Testing
Service type Molecular Genetic Analysis
Duration 7-14 business days
Fasting Fasting is not required

Included Services

  • Sample collection or biopsy processing
  • Next-Generation Sequencing (NGS) analysis
  • Detailed medical report

Medical Service Information

Importance of the Test

  • Identifying patients eligible for targeted TRK inhibitor therapies.
  • Providing treatment options for advanced or metastatic solid tumors.
  • Improving the accuracy of genetic cancer diagnosis.

Target Groups

  • Patients with advanced or metastatic solid tumors.
  • Patients who have not responded to conventional treatments.
  • Rare cancer cases with a high probability of gene fusion.

Technology Used

  • Utilizes Next-Generation Sequencing (NGS) to screen NTRK1, NTRK2, and NTRK3 genes.
  • High sensitivity in detecting complex structural gene fusions.

Conditions & Notices

  • A tumor biopsy or blood sample (liquid biopsy) must be provided as per physician guidance
  • Provide previous medical reports related to the tumor type

Medical services you might also like